Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    New history entry dated 2025-07-28 added, updating the study status and oversight details.
    Difference
    0.1%
    Check dated 2025-10-27T20:53:35.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T07:54:16.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.3%
    Check dated 2025-09-29T04:17:55.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no other substantive content changes observed.
    Difference
    0.7%
    Check dated 2025-09-14T21:40:53.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.7%
    Check dated 2025-09-07T17:59:42.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.
    Difference
    18%
    Check dated 2025-08-31T12:18:18.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.